BaCas12a3 represents a new subtype of type V CRISPR effector with collateral activity toward tRNA.
- DOI
- 10.1093/nar/gkag915
- Published
- 2026 Sep 22
- Container
- Nucleic acids research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/nar/gkag915,
title = {BaCas12a3 represents a new subtype of type V CRISPR effector with collateral activity toward tRNA.},
author = {Li X and Wu C and Guo J and Zheng R and Kong J and Du L and She Q and Ji S},
year = {2026},
journal = {Nucleic acids research},
doi = {10.1093/nar/gkag915},
url = {https://doi.org/10.1093/nar/gkag915}
}RIS
TY - JOUR TI - BaCas12a3 represents a new subtype of type V CRISPR effector with collateral activity toward tRNA. AU - Li X AU - Wu C AU - Guo J AU - Zheng R AU - Kong J AU - Du L AU - She Q AU - Ji S PY - 2026 JO - Nucleic acids research DO - 10.1093/nar/gkag915 UR - https://doi.org/10.1093/nar/gkag915 ER -
APA
X, L., C, W., J, G., R, Z., J, K., L, D., Q, S., & S, J. (2026). BaCas12a3 represents a new subtype of type V CRISPR effector with collateral activity toward tRNA.. Nucleic acids research. https://doi.org/10.1093/nar/gkag915
Source records
- pubmed · retrieved 2026-09-25T06:37:48.127Z